Frequently Asked Questions
Answers to our most frequently asked questions are just one click away.
Filter by Type
Still Need Help?
1 The Centers for Medicare and Medicaid Services (CMS) have indicated that at-home COVID-19 tests, such as the one eMed provides, must be covered by insurers and health plans when the test is ordered by an attending health care provider who has determined that the test is medically appropriate for the individual based on current accepted standards of medical practice and the test otherwise meets the statutory criteria in section 6001(a)(1) of the FFCRA. Consistent with section 6001 of the FFCRA, this coverage must be provided without imposing any cost-sharing requirements, prior authorization, or other medical management requirements. All eMed’s BinaxNOW COVID-19 Ag Card Home Tests are ordered by independent providers licensed to practice in the state of the test-taker, based on results from a screening questionnaire indicating that the test is medically appropriate for the individual. See also, FAQs regarding implementation of the Families First Coronavirus Response Act (the FFCRA), the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act), and other health coverage issues related to Coronavirus Disease 2019 (COVID-19) at https://www.cms.gov/files/document/FFCRA-Part-43-FAQs.pdf